That's a really important question, and it's great that you're thinking ahead about your health journey. The honest answer is that recurrence risk is different for everyone — there's no single number that applies to all.
Here are some key factors that influence your personal risk:
- Type and subtype of breast cancer (e.g Show Full Answer
That's a really important question, and it's great that you're thinking ahead about your health journey. The honest answer is that recurrence risk is different for everyone — there's no single number that applies to all.
Here are some key factors that influence your personal risk:
- Type and subtype of breast cancer (e.g., hormone receptor-positive, HER2-positive)
- Stage at diagnosis (tumor size, lymph node involvement, spread)
- Age at diagnosis (younger than 35 carries higher risk)
- How well treatment worked (no remaining cancer cells after treatment is a good sign)
- Lifestyle factors like weight, exercise, and alcohol intake For hormone receptor-positive breast cancer specifically, at least 50% of recurrences happen within the first five years. However, there is also a risk of what's called "late recurrence," meaning cancer can return 10 or more years after finishing treatment.
Arimidex reduces — but doesn't completely eliminate — recurrence risk, so staying on top of follow-up appointments after finishing it is really important. Asking your doctor about genomic testing is worth considering if you haven't already. It looks at specific genes in cancer cells and can give a clearer picture of your individual recurrence risk.
A conversation with your care team closer to the time you finish Arimidex will help you understand what monitoring and next steps make sense for you specifically. 💛
1 day ago
Join
Your Privacy Choices
